366 participants
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-10-14
- Start Date:
- 2016-03-02
- Completion:
- 2019-01-31
Conditions
- Epithelial Ovarian Cancer
- Primary Peritoneal Carcinoma
- Fallopian Tube Cancer
- Ovarian Cancer
Interventions
- DRUG